
TURNER SYNDROME WITH ISOCHROMOSOME Xq
AND FAMILIAL RECIPROCAL TRANSLOCATION
t(4;16)(p15.2;p13.1) Cetin Z1, Mendilcioglu I2, Yakut S1, Berker-Karauzum S1,*, Karaman B3, Luleci G1 *Corresponding Author: Sibel Berker-Karauzum, Department of Medical Biology and Genetics, Faculty of
Medicine, Akdeniz University, Antalya, Turkey; Tel.: +90-242-249-69-70; Fax: + 90-242-227-44-82/227-44-95;
E-mail: sibelkarauzum@akdeniz.edu.tr page: 57
|
DISCUSSION
The coexistence of a balanced translocation and
a chromosome X abnormality in Turner syndrome
patients is rarely reported in the literature [4-10].
Four cases were carriers of a parentally transmitted
Robertsonian translocation and had the non mosaic
44,X,t(13;14)(q10;q10) karyotype [4-7]. Of these,
three had inherited the translocation from their mothers
and one from the father [4,7]. No other family members
carried the translocation and sex chromosomal
abnormality in these reports. There are three Turner
syndrome patients with a familial balanced reciprocal
translocation and monosomy of the X chromosome in
the literature [8-10]. In these reports ,the reciprocal
translocations were t(2;22)(q?;q?),t(1;22)(q32;q21)
and t(8:19) (p21:p13), and no other family member
was affected by sex chromosome abnormalities in two
reports [9,10]. However, a boy with true hermaphroditism
and 46,XX/46,XY mosaicism formed part of
the family reported by Anneren et al. [8].
Our Turner syndrome patient had reciprocal translocation
and structural abnormality of the X chromosome
(isochromosome Xq). The clinical picture of our
patient was mild and this finding is concordant with
the previous reports indicating that most of the Turner
syndrome patients with structural X chromosome abnormalities
had mild phenotypes [12,13]. The numerical
chromosome X abnormalities in low-level mosaic
state observed in the mother was not associated with
phenotypic abnormalities. However, the spontaneous
abortion of the third pregnancy of the mother might be
associated with the balanced translocation.
As proposed by James et al. [14], the absence of
a 46,XX cell line in our patient could suggest that a
post-zygotic mechanism is not likely, unless the errors
occurred during the first post-zygotic mitotic cell division.
Alternatively, the patient may have been conceived
with the karyotype 46,X,i(Xq) in a non mosaic state and
a subsequent loss of the isochromosome from a proportion
of cells resulted in the 45,X/46,X,i(Xq) karyotype
[14]. There are several proposed mechanisms resulting
in formation of isochromosome Xq. Generally,
isochromosome Xq chromosomes are structurally dicentric
chromosomes containing proximal Xp material
suggesting that the most likely mechanism of formation
is chromatid breakage and reunion in proximal Xp [15].
The more intense centromeric α satellite DNA signal
on the isochromosome Xq observed in our case suggests
that chromatid breakage and reunion in proximal
Xp could be acceptable as a mechanism of formation in
our case. Previous molecular genetic studies in patients
with structural balanced translocations and monosomy
X have excluded a meiotic non disjunction interchromosomal
effect [4]. Unfortunately, we could not apply
molecular genetic studies to show a possible effect of
the maternal balanced translocation on the formation of
isochromosome Xq because the family members were
unavailable for further molecular genetic studies.
As a result, in some Turner syndrome patients
with structural chromosome X abnormalities accompanied
by the familial transmitted balanced translocation,
the carrier parents might have chromosome X
abnormalities in a mosaic state. Therefore, the parental
chromosomes should be evaluated to rule out possible
low level numerical/structural chromosome X abnormalities
which may be important for the management
of further pregnancies.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|